Publications by authors named "Sunanda Dastidar"

Claim this Profile
I
Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
Ruchi Tandon, Ajay Soni, Rakesh K Singh, Reena Sodhi, Mahesh K Seth, Sunanda G Dastidar

Eur J Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological functions and role of mitogen-activated protein kinase activated protein kinase 2 (MK2) in inflammatory diseases.
Rakesh Kumar Singh, Abul Kalam Najmi, Sunanda Ghosh Dastidar

Pharmacol Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
Sushmita Chakraborty, Puneet Chopra, Senthil V Ambi, Sunanda G Dastidar, Abhijit Ray

Expert Opin Investig Drugs· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review on leukotrienes and their receptors with reference to asthma.
Rakesh Kumar Singh, Ruchi Tandon, Sunanda Ghosh Dastidar, Abhijit Ray

J Asthma· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy.
Ruchi Tandon, V Senthil, D Nithya, Venu Pamidiboina, Ankur Kumar, Sunanda G Dastidar

Eur J Pharmacol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis.
Sushmita Chakraborty, Puneet Chopra, Anushree Hak, Sunanda Ghosh Dastidar, Abhijit Ray

Expert Opin Investig Drugs· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of 4,5-dihydro-5-methylisoxazolin-5-carboxamide derivatives as VLA-4 antagonists.
Ajay Soni, Abdul Rehman, Keshav Naik, Sunanda Dastidar, M S Alam

Bioorg Med Chem Lett· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 3,5-disubstituted-1,2,4-oxadiazoles as potent inhibitors of phosphodiesterase4b2.
Dalip Kumar, Gautam Patel, Lalitha Vijayakrishnan, Sunanda G Dastidar, Abhijit Ray

Chem Biol Drug Des· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COX inhibitors for airway inflammation.
Sanjay Malhotra, Sangram Shesharao Deshmukh, Sunanda Ghosh Dastidar

Expert Opin Ther Targets· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment.
Ruchi Tandon, Shweta Kapoor, Shireen Vali, V Senthil, D Nithya, Sunanda G Dastidar

Eur J Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonist.
Suman Gupta, Shivani Malhotra, Sandeep Sinha, Shashi K Singh, Rakesh K Singh, Sunanda G Dastidar

Eur J Pharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of nonradioactive cell-free cAMP assays for measuring in vitro phosphodiesterase activity.
Mathew S Eapen, Reena Sodhi, Gayathri Balakrishnan, Sunanda Dastidar, Abhijit Ray

Pharmacology· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.
Abdul Rehman, Ajay Soni, Keshav Naik, Sreeji Nair, Venkata P Palle, Sunanda Dastidar

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
Puneet Chopra, Onkar Kulkarni, Shashank Gupta, Malini Bajpai, Vijay Kanoje, Sunanda G Dastidar

Int Immunopharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.
Rishabh Dev, Punit Kumar Srivastava, Jitesh P Iyer, Sunanda G Dastidar, Abhijit Ray

Expert Opin Investig Drugs· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics.
Puneet Chopra, Gautam Sethi, Sunanda G Dastidar, Abhijit Ray

Expert Opin Investig Drugs· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
Suman Gupta, Rakesh Kumar Singh, Kamna Nanda, Mou Chatterjee, Atul Tiwari, Sunanda Dastidar

J Recept Signal Transduct Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of a novel, orally active PDE4 inhibitor.
Sunanda G Dastidar, Abhijit Ray, Rajkumar Shirumalla, Deepa Rajagopal, Shiwani Chaudhary

Pharmacology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin E(2) synthase inhibition as a therapeutic target.
Jitesh P Iyer, Punit K Srivastava, Rishabh Dev, Sunanda G Dastidar, Abhijit Ray

Expert Opin Ther Targets· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of cell death-based method for the selectivity screening of caspase-1 inhibitors.
Puneet Chopra, Shashank Gupta, Sunanda G Dastidar, Abhijit Ray

Cytotechnology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system.
Kamna Nanda, Mou Chatterjee, Ranjana Arya, Shohini Mukherjee, Kulvinder Singh Saini, Sunanda Dastidar

Biotechnol J· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
Puneet Chopra, Kamna Nanda, Mou Chatterjee, Malini Bajpai, Sunanda G Dastidar

Anal Biochem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK2: a novel molecular target for anti-inflammatory therapy.
Senthil Duraisamy, Malini Bajpai, Usha Bughani, Sunanda G Dastidar, Abhijit Ray

Expert Opin Ther Targets· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting of E3 ligases--a therapeutic approach for cancer.
Manikandan Lakshmanan, Usha Bughani, Senthil Duraisamy, Manish Diwan, Sunanda Dastidar

Expert Opin Ther Targets· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis.
Malini Bajpai, Puneet Chopra, Sunanda G Dastidar, Abhijit Ray

Expert Opin Investig Drugs· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis